Spatiotemporal Origin and Cross-Regional Transmission Dynamics of HIV-1 Circulating Recombinant Form (CRF85_BC) in Developed Eastern China: A Seven-Year Comprehensive Molecular Surveillance Study - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Geographic and Temporal Origins and Spread of HIV-1 CRF85_BC Across Developed Eastern China: Findings from Seven Years of Molecular Surveillance

  • By

  • Qin Fan

  • Jiafeng Zhang

  • Jun Jiang

  • Hehe Zhao

  • Xiaohong Pan

  • Hui Xing

  • Yaping Yao

  • Yi Feng

  • Yong Yan

  • Xiaobei Ding

  • Wei Cheng

  • Xin Zhou

  • Yan Xia

  • Chengliang Chai

  • Jianmin Jiang

  • October 24, 2026

Share

Clinical Scorecard: Geographic and Temporal Origins and Spread of HIV-1 CRF85_BC Across Developed Eastern China: Findings from Seven Years of Molecular Surveillance

At a Glance

Category

Detail

Condition

HIV-1 infection with the circulating recombinant form CRF85_BC

Key Mechanisms

CRF85_BC is a B/C chimeric recombinant with breakpoints across the pol and env regions; the study examines its introduction, local transmission, and geographic spread.

Target Population

Newly diagnosed HIV-1-infected individuals in Zhejiang Province, China, with CRF85_BC infection and eligible epidemiological data and sequence quality.

Care Setting

Province-wide HIV molecular surveillance in Zhejiang, eastern China, from 2017 through 2023.

Key Highlights

  • This retrospective, population-based study analyzed 259 people with CRF85_BC infection identified from 2017 through 2023.

  • CRF85_BC was detected in Zhejiang in 2017 and had reached all 11 prefecture-level cities by 2023, becoming the province’s fifth most prevalent HIV-1 subtype.

  • Phylogeographic analysis indicated repeated introductions from Sichuan and Yunnan, followed by sustained transmission within Zhejiang centered on Jiaxing.

  • Molecular network analysis identified 183 people (70.66%) in 41 clusters. Jiaxing accounted for 48.63% of clustered cases; 58.60% of genetic linkages connected two Jiaxing cases.

Guideline-Based Recommendations

The article presents surveillance findings and the authors’ public health recommendations rather than a clinical practice guideline.

Diagnosis

  • Surveillance combined laboratory-confirmed HIV diagnoses with epidemiological information and qualifying HIV-1 pol sequences.

  • Preliminary subtyping used COMET, followed by confirmation using maximum-likelihood phylogenetic analysis and the Los Alamos National Laboratory HIV BLAST tool.

Management

  • The authors recommend strengthening antiretroviral therapy management to maintain viral suppression in core transmission clusters.

  • They also recommend targeted partner notification and promotion of preexposure prophylaxis to interrupt ongoing transmission.

Monitoring & Follow-up

  • The findings support routine provincial molecular surveillance and cross-provincial collaborative monitoring.

  • Linking sequence data with demographic, geographic, and transmission-route information can help identify affected populations and core clusters.

Risks

  • Heterosexual contact accounted for 241/259 infections (93.05%).

  • Adults aged 60 years or older had higher clustering before adjustment, but age was not independently associated with clustering after adjustment.

  • Nonlocal household registration remained independently associated with lower clustering odds.

  • Several members of the four large clusters had detectable viremia despite recorded antiretroviral therapy, indicating a need for improved viral suppression.

Patient & Prescribing Data

The cohort included 259 newly diagnosed individuals: 181 (69.88%) were male, 191 (73.75%) were aged 50 years or older, and 115 (44.40%) were aged 60 years or older. Permanent Zhejiang residents accounted for 122 cases (47.10%); 137 (52.90%) had nonlocal household registration.

The study was not a treatment trial. It reported treatment-status and viral-load information for members of the four large clusters, including detectable viremia in some individuals with recorded antiretroviral therapy. It did not establish a CRF85_BC-specific prescribing regimen.

Clinical Best Practices

  • Apply standardized sequence-quality criteria and subtype verification in molecular surveillance.

  • Combine molecular findings with demographic and geographic information when prioritizing public health responses.

  • Interpret older adults’ higher clustering alongside residence and other population characteristics.

  • Recognize the study’s limitations: analysis of the pol region alone, possible selection bias from undiagnosed infections and sequencing failures, and absence of individual-level behavioral survey data.

  • Avoid interpreting the observed clustering rate as proof of greater intrinsic transmissibility; the authors could not distinguish viral properties from population network structure.

Related Resources & Content

  • Spatiotemporal origin and cross-regional transmission dynamics of HIV-1 circulating recombinant form (CRF85_BC) in developed eastern China: a 7-year comprehensive molecular surveillance study — Qin Fan, Jiafeng Zhang, Jun Jiang, et al. — International Journal of Infectious Diseases. 2026;173:109207. doi:10.1016/j.ijid.2026.109207.

  • Identification of a novel HIV-1 circulating recombinant form (CRF85_BC) in Sichuan, China — Su L, Wei D, Yang H, et al. — AIDS Research and Human Retroviruses. 2016;32(9):895–899. doi:10.1089/aid.2016.0053.

  • Rapid circulation of HIV-1 CRF85_BC in Southwest China: its geographic origins and molecular transmission networks analysis — Liu Y, Yang C, Chang W, et al. — Frontiers in Cellular and Infection Microbiology. 2025;15:1624996. doi:10.3389/fcimb.2025.1624996.

Original Source(s)

Related Content